Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Faran Quantum Genomics to receive up to $12.1 million in upfront and milestone payments plus double-digit royalties on sales Faran to receive an exclusive license to develop and commercialize firibastat for the treatment of difficult to treat/resistant hypertension in Greece PARIS and NEW YORK, Dec. 15, 2020 — Quantum Gen...
Source: globalbankingandfinance.com